154 related articles for article (PubMed ID: 36993526)
1. DRPPM-PATH-SURVEIOR: Plug-and-Play Survival Analysis of Pathway-level Signatures and Immune Components.
Obermayer A; Chang D; Nobles G; Teng M; Tan AC; Wang X; Eschrich S; Rodriguez P; Grass GD; Meshinchi S; Tarhini A; Chen DT; Shaw T
Res Sq; 2023 Mar; ():. PubMed ID: 36993526
[TBL] [Abstract][Full Text] [Related]
2. PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing.
Obermayer AN; Chang D; Nobles G; Teng M; Tan AC; Wang X; Chen YA; Eschrich S; Rodriguez PC; Grass GD; Meshinchi S; Tarhini A; Chen DT; Shaw TI
BMC Bioinformatics; 2023 Jun; 24(1):266. PubMed ID: 37380943
[TBL] [Abstract][Full Text] [Related]
3. DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer Datasets.
Obermayer A; Dong L; Hu Q; Golden M; Noble JD; Rodriguez P; Robinson TJ; Teng M; Tan AC; Shaw TI
Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205126
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
Zhang B; Yang L; Wang X; Fu D
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
7. Comparison of multi-omics results between patients with acute myeloid leukemia with long-term survival and healthy controls.
Song Y; Hao Q; Zhang G; Fang Q; Wang Z; Li Y; Wei H; Wang Y; Jiang E; Tian Z; Jia Y; Wang M; Wang J; Mi Y
Ann Transl Med; 2022 Jan; 10(2):82. PubMed ID: 35282130
[TBL] [Abstract][Full Text] [Related]
8. Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
Zhang L; Han X; Shi Y
JAMA Netw Open; 2020 Aug; 3(8):e2013201. PubMed ID: 32845327
[TBL] [Abstract][Full Text] [Related]
9. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma.
Liu D; Yang X; Wu X
Front Immunol; 2021; 12():663495. PubMed ID: 34025664
[TBL] [Abstract][Full Text] [Related]
10. Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia.
Wang W; Liang Q; Zhao J; Pan H; Gao Z; Fang L; Zhou Y; Shi J
Front Genet; 2022; 13():970316. PubMed ID: 36246603
[TBL] [Abstract][Full Text] [Related]
11. A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia.
Liu X; Wang L; Kang Q; Feng C; Wang J
Front Pharmacol; 2024; 15():1339465. PubMed ID: 38482057
[No Abstract] [Full Text] [Related]
12. Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures.
Hossain SM; Gimenez G; Stockwell PA; Tsai P; Print CG; Rys J; Cybulska-Stopa B; Ratajska M; Harazin-Lechowska A; Almomani S; Jackson C; Chatterjee A; Eccles MR
Front Immunol; 2022; 13():955063. PubMed ID: 36248850
[TBL] [Abstract][Full Text] [Related]
13. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
14. Increased NFATC4 Correlates With Poor Prognosis of AML Through Recruiting Regulatory T Cells.
Zhao C; Yang S; Lu W; Liu J; Wei Y; Guo H; Zhang Y; Shi J
Front Genet; 2020; 11():573124. PubMed ID: 33329712
[TBL] [Abstract][Full Text] [Related]
15. Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia.
Ni J; Wu Y; Qi F; Li X; Yu S; Liu S; Feng J; Zheng Y
Front Oncol; 2019; 9():1509. PubMed ID: 32039005
[No Abstract] [Full Text] [Related]
16. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
17. Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment.
Johansson PA; Hayward NK; Pritchard AL
Pigment Cell Melanoma Res; 2023 Mar; 36(2):246-251. PubMed ID: 36617535
[TBL] [Abstract][Full Text] [Related]
18. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
19. Survival prediction in acute myeloid leukemia using gene expression profiling.
Lai B; Lai Y; Zhang Y; Zhou M; OuYang G
BMC Med Inform Decis Mak; 2022 Mar; 22(1):57. PubMed ID: 35241089
[TBL] [Abstract][Full Text] [Related]
20. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
